MyAverix Finance
US · Healthcare
Novo Nordisk A/S (NVO)
Drug Manufacturers - General
Novo Nordisk A/S (NVO) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-05-24, reported market cap is $199.25B, P/E ratio is 18.00, net margin is 37.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NVO
Novo Nordisk A/S (NVO) — FAQ
What is Novo Nordisk A/S's market cap?
Novo Nordisk A/S (NVO) has a reported market cap of $199.25B (data as of 2026-05-24).
What is NVO's P/E ratio?
The price-to-earnings (P/E) ratio for Novo Nordisk A/S (NVO) is 18.00 (data as of 2026-05-24).
Does Novo Nordisk A/S pay a dividend?
Dividend yield is not available in the current snapshot for Novo Nordisk A/S (NVO). Check the MyAverix Finance app for the latest dividend data.
What sector is Novo Nordisk A/S in?
Novo Nordisk A/S (NVO) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is NVO listed on?
NVO is listed on US.
What is Novo Nordisk A/S's net margin?
Novo Nordisk A/S (NVO) reports a net margin of 37.2% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.